{"id":17,"date":"2022-03-02T10:23:38","date_gmt":"2022-03-02T10:23:38","guid":{"rendered":"http:\/\/box5546.temp.domains\/~metpharm\/?page_id=17"},"modified":"2024-05-11T20:32:30","modified_gmt":"2024-05-11T20:32:30","slug":"stakeholders","status":"publish","type":"page","link":"https:\/\/met-pharm.com\/?page_id=17","title":{"rendered":"Stakeholders"},"content":{"rendered":"\n <\/div>
\n <\/a>\n \n <\/div>
\n \n
<\/div>\n \n<\/div>\n\n
\n \n <\/div>
<\/div> <\/div><\/div><\/div><\/div>

Stakeholders <\/b><\/font><\/span><\/h2>

At Metpharm R&D, we understand the vital role of collaboration in driving progress within the pharmaceutical and medical device sectors. With our seasoned team boasting extensive experience across various domains including pharmaceuticals, medical devices, public institutions, and academia, we offer strategic partnership opportunities tailored to meet the unique needs of each project. From the initial stages of product development to navigating reimbursement processes and ensuring patient access, we are committed to providing comprehensive support at every step.\n

\nOur approach is characterized by a multidisciplinary mindset and a wealth of expertise, bolstered by strategic partnerships forged at both national and international levels. By leveraging this collective experience, we have cultivated an effective service network, positioning ourselves as your trusted solution partner. Our services encompass the entire spectrum of project requirements, from ideation to execution, with a focus on delivering tangible results.\n

\nWith a robust network and a reputation for reliability, Metpharm R&D serves as a cornerstone for collaboration in both the public and private sectors. We prioritize building and maintaining constructive relationships with stakeholders across the industry, fostering an environment conducive to innovation and growth.\n


Some of Our Strategic Partners<\/b>

\n<\/font>
Asphalion               HIPRA                                 \u00d6zbay Sa\u011fl\u0131k 

Delta-Med             Impact Health                Statin_Med<\/b>

Diagenics                KUISCID                            Tuniva<\/b>

DxNow                     Mentor AR-GE               Turkishtime <\/b>

GenX                          Monitor CRO<\/b>


\n\nSome of the Institutions and Companies We Have Served (2014-2024)<\/b><\/font>

Our extensive client portfolio includes collaborations with leading institutions and companies in the pharmaceutical and medical industries. These partnerships reflect our commitment to excellence and innovation, driving forward projects that have a meaningful impact on healthcare.<\/font>
\n<\/font>
Abdi \u0130brahim\n

A\u0130FD\n

Alexion\n

Allergan\n

Astra Zeneca\n

Berko \u0130la\u00e7\n

BioMarin\n

Boehringer Ingelheim\n

Boston Scientific\n

BTG Medical\n

Bugamed\n

Celgene\n

Centurion \u0130la\u00e7\n

Cordamed-Intiutive\n

Daichi Sankyo\n

Deva \u0130la\u00e7\n

Guerbet \u0130la\u00e7\n

HIPRA\nHorizon Health 2021 European Union Project\n

Illumina\n

Intra Medikal\n

\u0130brahim Etem Menarini\n

\u0130stanbul \u0130la\u00e7\n

Johnson and Johnson\n

Kansuk \u0130la\u00e7\n

Konsina\n

Lilly\n

Med \u0130la\u00e7\n

MEDSALUS\n

MT Sa\u011fl\u0131k\n

Pierre Fabre \u0130la\u00e7\n

Ra \u0130la\u00e7\n

Roche\n

Sanofi\n

TRPharm\n

T\u00fcrk Philips\n

UTSAT sa\u011fl\u0131k\n

Vivasante\n

Zentiva\n<\/b>

Through collaboration and innovation, we continue to drive positive change in the healthcare landscape. 
<\/span><\/p>

<\/div><\/div><\/div><\/div><\/div>\n <\/div>\n<\/section>\n